UTHR

503.90

0.06% 0.30

Dopo l'orario di chiusura: 499.00 -4.90 -0.97%

United Therapeutics Corp (UTHR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché UTHR Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$503.60

Aprire:

$503.7

Volume 24 ore:

607.44K

Relative Volume:

1.57

Capitalizzazione di mercato:

$21.70B

Reddito:

$3.13B

Utile/perdita netta:

$1.27B

Rapporto P/E:

19.10

EPS:

26.3851

Flusso di cassa netto:

$1.12B

1 W Prestazione:

+6.44%

1M Prestazione:

+5.69%

6M Prestazione:

+65.03%

1 anno Prestazione:

+55.71%

Intervallo 1D:

$491.97

$507.93

Intervallo di 1 settimana:

$466.00

$537.19

Portata 52W:

$266.98

$537.19

United Therapeutics Corp Stock (UTHR) Company Profile

Nome

United Therapeutics Corp

Settore

Healthcare (1111)

Industria

Drug Manufacturers - Specialty & Generic (83)

Telefono

(301) 608-9292

Indirizzo

1000 SPRING ST, SILVER SPRING, MD

Dipendente

1,305

Cinguettio

Prossima data di guadagno

2026-02-25

Ultimi documenti SEC

UTHR's Discussions on Twitter

Compare UTHR vs TAK, ZTS, HLN, TEVA

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
UTHR United Therapeutics Corp	503.90	21.68B	3.13B	1.27B	1.12B	26.39
TAK Takeda Pharmaceutical Co Adr	18.75	58.54B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	131.10	54.78B	9.47B	2.67B	2.28B	6.0218
HLN Haleon Plc Adr	11.07	47.92B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	33.86	39.33B	17.41B	1.43B	1.00B	1.2182

United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-20	Iniziato	Wells Fargo	Underweight
2025-09-26	Iniziato	RBC Capital Mkts	Outperform
2025-06-02	Iniziato	Cantor Fitzgerald	Overweight
2025-04-25	Downgrade	Wells Fargo	Overweight → Equal Weight
2025-04-21	Aggiornamento	BofA Securities	Underperform → Neutral
2024-07-11	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2024-02-12	Aggiornamento	Goldman	Sell → Neutral
2024-02-05	Iniziato	Leerink Partners	Outperform
2023-12-08	Iniziato	Wells Fargo	Overweight
2022-12-06	Iniziato	UBS	Buy
2022-12-05	Iniziato	Goldman	Sell
2022-10-11	Iniziato	Morgan Stanley	Overweight
2022-09-20	Reiterato	BofA Securities	Underperform
2022-09-19	Ripresa	Wedbush	Outperform
2022-02-11	Iniziato	BTIG Research	Neutral
2021-07-14	Aggiornamento	Argus	Hold → Buy
2021-04-26	Ripresa	Credit Suisse	Outperform
2021-02-01	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-09-14	Ripresa	JP Morgan	Overweight
2020-06-25	Reiterato	H.C. Wainwright	Neutral
2020-03-10	Aggiornamento	Jefferies	Hold → Buy
2020-02-27	Aggiornamento	Cowen	Market Perform → Outperform
2020-01-31	Aggiornamento	JP Morgan	Neutral → Overweight
2019-12-03	Iniziato	BofA/Merrill	Underperform
2019-08-01	Aggiornamento	Jefferies	Underperform → Hold
2019-08-01	Aggiornamento	Ladenburg Thalmann	Neutral → Buy
2019-07-01	Aggiornamento	Credit Suisse	Neutral → Outperform
2019-05-17	Aggiornamento	UBS	Sell → Neutral
2019-05-09	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-10-12	Aggiornamento	Standpoint Research	Hold → Buy
2018-08-08	Downgrade	Credit Suisse	Neutral → Underperform
2018-04-03	Aggiornamento	Credit Suisse	Underperform → Neutral
2018-02-22	Reiterato	Barclays	Underweight
2018-01-18	Ripresa	Credit Suisse	Underperform
2017-12-27	Reiterato	Wedbush	Outperform
2017-04-27	Reiterato	Wedbush	Outperform
2017-03-30	Iniziato	UBS	Sell
2017-03-16	Iniziato	Credit Suisse	Underperform

Mostra tutto

United Therapeutics Corp Borsa (UTHR) Ultime notizie

08:27 AM

United Therapeutics Corp. Experiences Revision in Its Stock Evaluation Amid Strong Financial Metrics - Markets Mojo

08:27 AM

Feb 26, 2026

United Therapeutics Corp. Hits New 52-Week High at $537.11 - Markets Mojo

Feb 26, 2026

H.C. Wainwright raises United Therapeutics stock price target to $600 - Investing.com Nigeria

Feb 26, 2026

United Therapeutics Hits Day High with 13% Surge in Strong Intraday Performance - Markets Mojo

Feb 26, 2026

United Therapeutics (NASDAQ:UTHR) Given New $600.00 Price Target at HC Wainwright - MarketBeat

Feb 26, 2026

These Analysts Increase Their Forecasts On United Therapeutics After Upbeat Q4 Earnings - Benzinga

Feb 26, 2026

MannKind’s Stock Plummets as United Therapeutics Unveils Rival Product - StocksToTrade

Feb 26, 2026

Wells Fargo & Company Issues Positive Forecast for United Therapeutics (NASDAQ:UTHR) Stock Price - MarketBeat

Feb 26, 2026

United Therapeutics Corporation (NASDAQ:UTHR) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 26, 2026

MANNKIND CORP SEC 10-K Report - TradingView

Feb 26, 2026

United Therapeutics Q4 Earnings Call Highlights - Yahoo Finance

Feb 26, 2026

Decoding United Therapeutics Corp (UTHR): A Strategic SWOT Insig - GuruFocus

Feb 26, 2026

TD Cowen raises United Therapeutics stock price target on growth outlook - Investing.com Nigeria

Feb 26, 2026

Feb 25, 2026

BofA raises United Therapeutics stock price target on earnings beat By Investing.com - Investing.com Canada

Feb 25, 2026

MannKind stock plummets after partner United Therapeutics unveils new 'category killer product' - MSN

Feb 25, 2026

United Therapeutics (NASDAQ:UTHR) Director Christopher Causey Sells 1,000 Shares - MarketBeat

Feb 25, 2026